摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,2S,9S)-11-methyl-13-oxa-7,11-diazatricyclo[7.3.1.02,7]tridecane | 1075213-41-0

中文名称
——
中文别名
——
英文名称
(1R,2S,9S)-11-methyl-13-oxa-7,11-diazatricyclo[7.3.1.02,7]tridecane
英文别名
(1R,2S,9S)-11-methyl-13-oxa-7,11-diazatricyclo[7.3.1.02,7]tridecane
(1R,2S,9S)-11-methyl-13-oxa-7,11-diazatricyclo[7.3.1.0<sup>2,7</sup>]tridecane化学式
CAS
1075213-41-0
化学式
C11H20N2O
mdl
——
分子量
196.293
InChiKey
ILZBSUJXPXWVGB-GARJFASQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    15.7
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1R,2S,9S)-11-methyl-13-oxa-7,11-diazatricyclo[7.3.1.02,7]tridecanezinc diacetate四氢呋喃 为溶剂, 以80%的产率得到[N,N'-(1R,2S,7R,9S,11S)-11-methyl-13-oxa-7,11-diazatricyclo[7.3.1.0(2,7)]tridecane]zinc diacetate
    参考文献:
    名称:
    Unexpected activity of novel 9-oxabispidine zinc complexes in lactide polymerization
    摘要:
    The zinc dichlorido and zinc diacetato complexes of the chiral tricyclic 9-oxabispidine (1R,2S,9S)-11-methyl-13-oxa-7,11-diazatricyclo [7 3 1 0(27)] tridecane were prepared and characterized by X-ray crystallography. The latter complex was found to catalyze the solvent-free polymerization of D,L-lacticle to give polylactide (C) 2010 Elsevier B V All rights reserved
    DOI:
    10.1016/j.inoche.2009.12.024
  • 作为产物:
    描述:
    (1R,2S,5R)-2-(4-hydroxybutyl)-7-methyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane偶氮二甲酸二异丙酯三苯基膦 作用下, 以 甲苯 为溶剂, 反应 24.0h, 以80%的产率得到(1R,2S,9S)-11-methyl-13-oxa-7,11-diazatricyclo[7.3.1.02,7]tridecane
    参考文献:
    名称:
    Enantioselective total synthesis of the tricyclic 9-oxabispidine (1R,2S,9S)-11-methyl-13-oxa-7,11-diazatricyclo[7.3.1.02,7]tridecane
    摘要:
    The enantiomerically pure tricyclic 9-oxabispidine (1R,2S,9S)-11-methyl-13-oxa-7,11-diazatricyclo[7.3.1.0(2.7) ]tridecane, a potential substitute for (+)-sparteine in asymmetric synthesis, was prepared in 7 steps and in 11% overall yield from a chiral epoxy alcohol and (S)-epichlorohydrin. The key intermediate was a bicyclic 9-oxabispidine with an appropriately functionalized, endo-oriented side chain. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2008.08.002
  • 作为试剂:
    描述:
    4-甲氧基-α-甲基苯甲醇(1R,2S,9S)-11-methyl-13-oxa-7,11-diazatricyclo[7.3.1.02,7]tridecane 、 C11H20Br2N2OPd 、 氧气caesium carbonate 作用下, 以 氯仿 为溶剂, 反应 19.2h, 以33%的产率得到(R)-1-(4-甲氧基苯基)乙醇
    参考文献:
    名称:
    A Flexible Route to Chiral 2-endo-Substituted 9-Oxabispidines and Their Application in the Enantioselective Oxidation of Secondary Alcohols
    摘要:
    A new and flexible route to enantiomerically pure bi- and tricyclic 9-oxabispidines has been developed with use of (1R,5S)-7-methyl-2-oxo-9-oxa-3,7-diazabicyclo[3.3.1]nonane-3-carboxylic acid tert-butyl ester as the common late-stage intermediate. The 9-oxabispidines synthesized were evaluated as the chiral ligands in the Pd(II)-catalyzed oxidative kinetic resolution of secondary alcohols giving good to excellent selectivity factors of up to 19.
    DOI:
    10.1021/jo802409x
点击查看最新优质反应信息

文献信息

  • Chiral 2-<i>endo</i>-Substituted 9-Oxabispidines: Novel Ligands for Enantioselective Copper(II)-Catalyzed Henry Reactions
    作者:Matthias Breuning、David Hein、Melanie Steiner、Viktoria H. Gessner、Carsten Strohmann
    DOI:10.1002/chem.200901789
    日期:2009.11.23
    The CuCl2 complex of the tricyclic 9‐oxabispidine, which carries an 2‐endo,N‐anellated piperidine ring, is an excellent catalyst for enantioselective Henry reactions giving the S‐configured β‐nitro alcohols in 91–98 % ee (13 examples). Surprisingly, the analogous copper complexes of the bicyclic 9‐oxabispidines delivered the enantiocomplementary R‐configured products in 33–57 % ee. The respective transition
    开发了一种适用于克级的灵活方法,用于手性2-内基取代的9-氧杂哌啶。关键中间体是顺式构型的6-基甲基吗啉-2-腈,是由(R)-3-丙烷-1,2-二醇2-氯丙烯腈制得的。2-内型取代基是由Grignard加成,环化,并引入外切体选择性还原,从而家具在19-59%的产率的对映体纯二和三环9- oxabispidines。氯化亚铜2复合物中的三环9 oxabispidine的,其携带一个2-内型,N-稠合哌啶环,是对映选择性亨利反应给出一种极好的催化剂小号在91–98%ee中配置的β-硝基醇 (13个示例)。出人意料的是,双环9-氧杂啶类似的络合物以33–57 %ee的浓度提供了对映体互补的R构型产物 。讨论了各自的过渡状态。
  • Thieme Chemistry Journal Awardees - Where Are They Now? Bridgehead Lithiated 9-Oxabispidines
    作者:Matthias Breuning、Melanie Steiner、David Hein、Christian Hörl、Philipp Maier
    DOI:10.1055/s-0029-1217999
    日期:2009.10
    Bi- and tricyclic 9-oxabispidines are smoothly deprotonated at -78 ˚C by s-BuLi at one of the bridgehead carbon atoms to give α-lithio ethers, which were trapped with electrophiles in good yields. Rearrangements to ring-contracted N,O-acetals occurred upon warming in the absence of an electrophile. The α-lithio ether intermediates are presumably stabilized by negative hyperconjugation.
    双环和三环 9-oxabispidines 在 -78 ËC 温度下通过桥头碳原子上的 s-BuLi 顺利地去质子化,得到δ-代醚,并以良好的产率与亲电剂阱在一起。在没有亲电剂的情况下,升温后会发生重排,生成环收缩的 N,O-乙醛。δ-醚中间体可能是通过负超共轭作用稳定下来的。
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)